Ohm, your regulator list shows that LL downregulat

Quote:

---

Ohm, your regulator list shows that LL downregulates PI3K. Is there any new information in the article that would be applicable to LL, e.g., possible additions to your disease list?

---

Most of them related to vascular leakage are already on the disease list - kidney disease, heart disease, stroke, sepsis and Covid. The two ones that aren't are possibly retinopathy and ARDS but ARDS is also a byproduct of Covid and where leronlimab is of most use.